Salt-loaded nanoparticles boost mRNA delivery by popping endosomes like water balloons

Key Findings

🧠 Brain-targeting nanoparticles deliver mRNA across the blood-brain barrier

• Scientists developed polymeric micelles that target transferrin receptor 1 to smuggle mRNA into the brain after intravenous injection

• The system achieved 10-fold higher protein production in the brain compared to initial formulations while reducing off-target effects in other organs

• Key innovations included pH-responsive components for endosomal escape and precisely controlled antibody fragment density on the particle surface

👴 Age-adaptive vaccines rescue immune responses in older patients

• Researchers discovered that mRNA vaccines work poorly in aged mice because of impaired gene expression in distant organs like liver, lungs, and spleen—not just local immune problems

• A rationally selected lipid nanoparticle formulation restored systemic mRNA translation across age groups, fully rescuing vaccine effectiveness in aged mice

• The findings suggest optimizing nanoparticle formulations for sustained gene expression could enable age-adaptive vaccines without additional interventions

🍬 Sugar-coated nanoparticles precisely target different organs and immune cells

• Scientists systematically tested how different sugar molecules (glycans) on lipid nanoparticles control where they go in the body and which cells they target

• GM3- and GD1A-containing nanoparticles efficiently transfected antigen-presenting cells in lymph nodes while maintaining good physical properties

• These glycan-modified vaccines triggered both CD8+ and CD4+ T cell responses—the latter being rarely achieved with standard formulations—and showed better tumor control than benchmark vaccines

🦠 Virus-mimicking particles achieve 37% of lung cells transfected

• Researchers engineered self-assembling particles that mimic enveloped viruses using simplified virus-like peptides and tissue-targeting phospholipids

• The optimized lung-targeted particles transfected 37% of total lung cells, including 73% of endothelial cells and 28% of immune cells

• In a lung cancer model, particles loaded with IL-12 mRNA effectively suppressed tumor growth with excellent safety and capacity for repeated dosing

🔬 Immune pathway discovery explains why some vaccines cause fewer side effects

• Scientists identified a poorly reactogenic mRNA vaccine formulation and traced adverse reactions to HMGB1 release, inflammatory cytokine production, and neutrophil infiltration

• IL-1 emerged as the key mediator of vaccine side effects, but was dispensable for generating protective antibodies—confirmed in human vaccine recipients where IL-1 pathway activation correlated with fever severity but not antibody levels

• The findings reveal that inflammatory pathways causing side effects can be separated from those needed for immunity

🧬 New RNA parameters improve mRNA vaccine stability predictions

• Researchers developed the first set of parameters for predicting how 1-methyl-pseudouridine—a key modification in COVID vaccines—affects RNA folding stability

• Based on 208 optical melting experiments, they found that substituting regular uridine with 1-methyl-pseudouridine generally stabilizes RNA folding, with effects depending on surrounding sequence

• The new parameters significantly improved predictions of tRNA folding and are now available in the RNAstructure software package for designing mRNA therapeutics